References
- American College of Obstetricians and Gynecologists Practice Bulletin Number 77. Screening for fetal chromosomal abnormalities. Washington, DC: American College of Obstetricians and Gynecologists; 2007
- Chiang HH, Chao YM, Yuh YS. Informed choice of pregnant women in prenatal screening tests for Down’s syndrome. J Med Ethics 2006;32:273–77
- Gekas J, Gondry J, Mazur S, et al. Informed consent to serum screening for Down syndrome: are women given adequate information? Prenat Diagn 1999;19:1–7
- Press N, Browner CH. Why women say yes to prenatal diagnosis. Soc Sci Med 1997;45:979–89
- Seavilleklein V. Challenging the rhetoric of choice in prenatal screening. Bioethics 2009;23:68–77
- Green JM, Hewison J, Bekker HL, et al. Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review. Health Technol Assess 2004;8:1–124
- Marteau TM, Johntson M, Plenicar M, et al. Development of a self-administered questionnaire to measure women’s knowledge of prenatal screening and diagnostic tests. J Psychosom Res 1988;32:403–8
- Van den Berg M, Timmermans DRM, ten Kate LP, et al. Informed decision making in the context of prenatal screening. Patient Educ Couns 2006;63:110–17
- Goel V, Glazier R, Holzapfel S, et al. Evaluating patient’s knowledge of maternal serum screening. Prenat Diagn 1996;16:425–30
- Hunter AGW, Cappelli M, Humphreys L, et al. A randomized trial comparing alternative approaches to prenatal diagnosis counseling in advanced maternal age patients. Clin Genet 2006;67:303–13
- Kaiser AS, Ferris LE, Pastuszak AL, et al. The effects of prenatal group genetic counseling on knowledge, anxiety and decisional conflict: issues for nuchal translucency screening. J Obstet Gynec 2002;22:246–55
- Kaiser AS, Ferris LE, Katz R, et al. Psychological responses to prenatal NTS counseling and the uptake of invasive testing in women of advanced maternal age. Patient Educ Couns 2004;54:45–53
- Sarkar R, Sowmyanarayanan TV, Samuel P, et al. Comparison of group counseling with individual counseling in the comprehension of informed consent: a randomized controlled trial. BMC Med Ethic 2010;11:1–6
- Jaques AM, Sheffield LJ, Halliday JL. Informed choice in women attending private clinics to undergo first-trimester screening for Down syndrome. Prenat Diagn 2005;25:656–64
- Van den Berg M, Timmermans DRM, ten Kate LP, et al. Are pregnant women making informed choices about prenatal screening? Genet Med 2005;7:332–33
- Gidiri M, McFarlane J, Holding S, Lindow SW. Maternal serum screening for Down syndrome: are women’s perceptions changing? BJOG 2007;114:458–61
- Gidiri M, Holding S, Lindow SW. Reduction in Down’s syndrome screening acceptance is predominantly observed in women aged 25–35 years. Women’s Health 2010;6:525–29
- Van den Berg M, Timmermans D RM, Kleinveld JH, et al. Accepting or declining the offer of prenatal screening for congenital defects: test uptake and women’s reasons. Prenat Diagn 2005;25:84–90
- Benn PA, Chapman AR. Practical and ethical considerations of noninvasive prenatal diagnosis. J Am Med Assoc 2009;301:2154–56
- Benn PA, Chapman AR. Ethical challenges in providing noninvasive prenatal diagnosis. Curr Opin Obstet Gynecol 2010;22:128–34